– USA, MA – Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the appointment of Robert Musslewhite as CEO, effective August 1, 2022., to succeed founder Jason Krantz who will become Executive Chairman.
“The Board of Directors and I are thrilled that Robert will serve as the next CEO of Definitive Healthcare,” said Krantz. “Robert brings a wealth of healthcare industry expertise and a successful track record of leading Software-as-a-Service healthcare information companies. He is the perfect person to lead Definitive Healthcare through our next period of growth, and I am excited to continue working in partnership with him.”
About Robert Musslewhite
Robert Musslewhite is currently President of Definitive Healthcare and has served as a member of the Board of Directors of the Company since June 2021. Since joining as President in October 2021, Musslewhite has been responsible for all commercial aspects of the business, including sales, marketing, and M&A. In his current role, he has led the rapid growth of the company’s commercial operations, including integration of recent key acquisitions, and he possesses significant experience with subscription business models and healthcare analytics. Musslewhite has worked closely with Krantz in developing and implementing the company’s growth strategy to date and is ideally skilled to lead it forward.
Prior to joining Definitive Healthcare, Robert Musslewhite served from August 2019 through August 2021 as CEO of OptumInsight, a $1.4 billion division of Optum, which uses a SaaS business model to deliver solutions that make clinical and administrative processes easier and more efficient across the healthcare ecosystem.
Robert Musslewhite joined Optum following Optum’s acquisition of The Advisory Board Company, a publicly traded company that used a subscription business model to deliver best practices research and insight, technology, data-enabled services, and consulting services. During his time as CEO from 2008 until 2017, The Advisory Board Company grew from approximately $200 million to $800 million in revenue. Before he was appointed CEO of OptumInsight, Musslewhite served as CEO of Optum360 from March 2019 until August 2019 and, before that, as CEO of Optum Analytics and CEO of Advisory Board Research from 2017 until March 2019. Before joining The Advisory Board Company, Musslewhite was an Associate Principal with McKinsey & Company, a global management consulting firm.
Robert Musslewhite currently serves on the Boards of Directors of CoStar Group (Nasdaq: CSGP), Ascend Learning, and Iodine Software. He is a member of the Economics Club of Washington D.C., and he recently completed service as Chair of the Board of Governors of St. Albans School.
“I am tremendously excited to take the helm at Definitive Healthcare and I am passionate about the company’s mission to transform data, analytics, and expertise into healthcare commercial intelligence. Definitive Healthcare has a great SaaS business model, with incredible customer retention, which just proves the value that the company delivers to its nearly 3,000 customers. I’m a big believer in the company and the culture that Jason and all the employees have built,”said Robert Musslewhite.
He added, “I also want to thank Jason for his amazing leadership over these last 11 years. It’s the rare CEO who can start a company, lead it through an IPO, and then surpass $200 million in annualized revenue run rate. I’m thrilled that he will continue as our Executive Chairman, and I look forward to partnering with Jason to take Definitive Healthcare to the next level.”
Musslewhite received a J.D. from Harvard Law School and an A.B. in Economics from Princeton University.
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data, analytics, and expertise into healthcare commercial intelligence. We help clients uncover the right markets, opportunities and people, so they can shape tomorrow’s healthcare industry. Our SaaS platform creates new paths to commercial success in the healthcare market, so companies can identify where to go next.
For more information: https://www.definitivehc.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.